November 18, 2024 1 min read Key takeaways: The PDUFA date for the resubmitted new drug application is April 2, 2025. Aldeyra has expanded an exclusive option agreement with AbbVie. The FDA has accepted the resubmitted new drug application for reproxalap, an investigational treatment for dry eye disease, and assigned a Prescription Drug User Fee Act date, according to … [Read more...] about Aldeyra receives PDUFA date for reproxalap, expands AbbVie option agreement
News
Long-term blood pressure variability and visual field progression in glaucoma
A newly published study1 reported that higher mean blood pressure (BP) levels and higher standard deviation (SD) of BP are associated with faster progression of visual field (VF) defects in patients with glaucoma.Vincent Q. Pham, BS, and colleagues from the Viterbi Family Department of Ophthalmology, Hamilton Glaucoma Center, Shiley Eye Institute, University of California, San … [Read more...] about Long-term blood pressure variability and visual field progression in glaucoma
Emmecell announces topline results from Phase 1 extension study of EO2002 for corneal edema
Emmecell today announced promising topline results from its U.S. multicenter Phase 1 extension study evaluating EO2002, a nonsurgical cell therapy for corneal edema.The company noted that its randomized, double-masked trial demonstrated improvements in vision and corneal health, along with a strong safety profile.¹Patients who received 150,000 endothelial cells exhibited an … [Read more...] about Emmecell announces topline results from Phase 1 extension study of EO2002 for corneal edema
Teprotumumab: TED treatment shows benefits for patients
The FDA approved teprotumumab-trbw (Tepezza; Amgen) in 2020 for treating thyroid eye disease (TED) following promising results from clinical trials. Although thousands of patients have received the monoclonal antibody, which targets the insulin-like growth factor 1 receptor, its use in clinical practice remains relatively new, and long-term real-world data remain limited.The … [Read more...] about Teprotumumab: TED treatment shows benefits for patients
BlephEx-treatment for blepharitis: a prospective randomized placebo-controlled trial
Blepharitis is a chronic inflammatory condition of the eyelids that affects a large proportion of patients in eye care settings. First-line treatments provide only partial relief for many patients. The BlephEx... … [Read more...] about BlephEx-treatment for blepharitis: a prospective randomized placebo-controlled trial
The analysis of foveal microvascular anomalies in retinopathy of prematurity after anti-vascular endothelial growth factor therapy using optical coherence tomography angiography
To investigate the quantitative vascular and structural differences in the foveal region of the eyes in retinopathy of prematurity children with or without anti-vascular endothelial growth factor (VEGF) therap... … [Read more...] about The analysis of foveal microvascular anomalies in retinopathy of prematurity after anti-vascular endothelial growth factor therapy using optical coherence tomography angiography
A rare case of infiltrative optic neuropathy caused by vitreoretinal lymphoma with hyperreflective deposits in the intraretinal and subretinal pigment epithelial layers prior to the disease onset
To describe a rare case of infiltrative optic neuropathy (ION) caused by vitreoretinal lymphoma (VRL) with hyperreflective deposits in the intraretinal and subretinal pigment epithelial (RPE) layers before the... … [Read more...] about A rare case of infiltrative optic neuropathy caused by vitreoretinal lymphoma with hyperreflective deposits in the intraretinal and subretinal pigment epithelial layers prior to the disease onset
Choroidal vascularity index in health and systemic diseases: a systematic review
Wei WB, Xu L, Jonas JB, Shao L, Du KF, Wang S, et al. Subfoveal choroidal thickness: the Beijing eye study. Ophthalmology. 2013;120(1):175–80.Article PubMed Google Scholar Agrawal R, Gupta P, Tan K-A, Cheung CMG, Wong T-Y, Cheng C-Y. Choroidal vascularity index as a measure of vascular status of the choroid: measurements in … [Read more...] about Choroidal vascularity index in health and systemic diseases: a systematic review
VIDEO: Vitreoretinal surgeons navigate new horizons, novel devices
November 17, 2024 3 min watch BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Matteo Forlini, MD, discusses a Vit-Buckle Society session on surgical challenges. Forlini highlighted the remarkable progress made in the field of vitreoretinal surgery. Minimally invasive systems, wide-angle viewing systems, intraoperative OCT and other new … [Read more...] about VIDEO: Vitreoretinal surgeons navigate new horizons, novel devices
Canada passes National Strategy for Eye Care Act
The Parliament of Canada has passed Bill C-284, better known to constituents as the National Strategy for Eye Care Act. In a press release from the Canadian Ophthalmological Society, vision health advocates celebrated the measure. Canada’s Vision Health Partners are a collective of eye care advocacy groups1 including Balance for Blind Adults, the Canadian Association of … [Read more...] about Canada passes National Strategy for Eye Care Act